4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0000921895-26-000895
Director sold 3,750,000 shares at $16.79 ($62,962,500)
From the SEC's structured data for this filing
Trades in this filing
BVF PARTNERS L P/IL · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-31 | Sale : show line 1 in the form | −1,932,354 | $16.79 | $32,444,224 | 8,302,735 | D |
| 2026-03-31 | Sale : show line 2 in the form | −1,569,116 | $16.79 | $26,345,458 | 6,599,722 | D |
| 2026-03-31 | Sale : show line 3 in the form | −248,530 | $16.79 | $4,172,819 | 1,039,238 | D |
| Open-market sales · 3,750,000 sh · avg $16.79 · $62,962,500 | ||||||
Loading xslF345X06/form407422mltx_04022026.xml…